![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
GW Pharm. | LSE:GWP | London | Ordinary Share | GB0030544687 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 735.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMGWP
RNS Number : 0174C
GW Pharmaceuticals PLC
23 June 2016
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) 1. Identity of the issuer or GW Pharmaceuticals PLC the underlying issuer of existing shares to which voting rights are attached: (ii) ----------------------------------------------------------- --------------------------- 2 Reason for the notification (please tick the appropriate box or boxes): ---------------------------------------------------------------------------------------- An acquisition or disposal of voting rights ------------------------------------------------------------ -------------------------- An acquisition or disposal of qualifying financial X instruments which may result in the acquisition of shares already issued to which voting rights are attached ------------------------------------------------------------ -------------------------- An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments ------------------------------------------------------------ -------------------------- An event changing the breakdown of voting rights ------------------------------------------------------------ -------------------------- Other (please specify): ---------------------------------------------------------- -------------------------- 3. Full name of person(s) Scopia Capital Management subject to the LP notification obligation: (iii) Scopia Management, Inc. ----------------------------------------------------------- --------------------------- 4. Full name of shareholder(s) Goldman Sachs & Co. (if different from 3.):(iv) ----------------------------------------------------------- --------------------------- 5. Date of the transaction 20 June 2016 and date on which the threshold is crossed or reached: (v) ----------------------------------------------------------- --------------------------- 6. Date on which issuer 22 June 2016 notified: ----------------------------------------------------------- --------------------------- 7. Threshold(s) that is/are crossed or reached: (vi, vii) 5% ----------------------------------------------------------- --------------------------- 8. Notified details: -------------------------------------------------------------------------------------------------------- A: Voting rights attached to shares (viii, ix) -------------------------------------------------------------------------------------------------------- Class/type Situation previous Resulting situation after the of to the triggering triggering transaction shares transaction if possible using the ISIN CODE -------------- ------------------------------ -------------------------------------------------------- Number Number Number Number of voting % of voting of of of shares rights rights (x) Shares Voting Rights -------------- -------------- -------------- ------------- -------------------- ------------------- Direct Direct Indirect Direct Indirect (xi) (xii) -------------- ------------ ------------ ------------- -------- ---------- -------- --------- Not Applicable -------------- -------------- ------------- -------- ---------- -------- --------- B: Qualifying Financial Instruments -------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction -------------------------------------------------------------------------------------------------------- Type of Expiration Exercise/ Number of voting % of voting financial date Conversion rights that rights instrument (xiii) Period (xiv) may be acquired if the instrument is exercised/ converted. ---------------- ------------- ----------------------------- ------------------- ------------------- American Depositary Receipts Not US36197T1034 Applicable Not Applicable 13,802,724 5.25% ---------------- ------------- ----------------------------- ------------------- ------------------- C: Financial Instruments with similar economic effect to Qualifying Financial Instruments (xv, xvi) -------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction -------------------------------------------------------------------------------------------------------- Type of Exercise Expiration Exercise/ Number of voting % of voting financial price date Conversion rights instrument rights (xix, instrument (xvii) period refers to xx) (xviii) --------------- ------------- ------------- -------------- -------------------- ------------------- Not Applicable Nominal Delta --------------- ------------- ------------- -------------- -------------------- -------- --------- Total (A+B+C) -------------------------------------------------------------------------------------------------------- Number of voting rights Percentage of voting rights ----------------------------------------------- ------------------------------------------------------- 13,802,724 5.25% ----------------------------------------------- ------------------------------------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: (xxi) ---------------------------------------------------------------------------------- Scopia Capital Management LP is the investment manager of certain funds that beneficially own the financial instruments disclosed in Section 8 of this form and which controls the voting rights attached those financial instruments. Scopia Management, Inc. is the general partner of Scopia Capital Management LP Proxy Voting: ---------------------------------------------------------------------------------- 10. Name of the proxy holder: Not Applicable --------------------------------------------- ----------------------------------- 11. Number of voting rights proxy holder will cease to hold: --------------------------------------------- ----------------------------------- 12. Date on which proxy holder will cease to hold voting rights: --------------------------------------------- ----------------------------------- 13. Additional information: ------------------------------------------- ------------------------------------- 14. Contact name: Samantha Nasello, Chief Compliance Officer ------------------------------------------- ------------------------------------- 15. Contact telephone number: +1.212.370.0304 ------------------------------------------- -------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLEAPKAAESKEFF
(END) Dow Jones Newswires
June 23, 2016 02:30 ET (06:30 GMT)
1 Year Gw Pharmaceuticals Chart |
1 Month Gw Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions